Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,853 papers from all fields of science
Search
Sign In
Create Free Account
KRH 594
Known as:
KRH-594
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (3)
Angiotensin II Type 1 Receptor Blockers
Tetrazoles
Thiadiazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Angiotensin II Receptor Subtypes Involved in the Modulation of Purinergic and Adrenergic Vasoconstrictions to Periarterial Electrical Nerve Stimulation in the Canine Splenic Artery
Xiao‐ping Yang
,
S. Chiba
Journal of Cardiovascular Pharmacology
2003
Corpus ID: 41466367
Summary: Previous experiments demonstrated that periarterial electrical nerve stimulation induced a double‐peaked…
Expand
2003
2003
Prejunctional AT(1) receptor subtype-dependent modification of neurotransmitter releases in canine isolated splenic arteries.
J. Komiyama
,
X-P Yang
,
S. Chiba
Autonomic & Autacoid Pharmacology
2003
Corpus ID: 39719910
1. The regulation by angiotensin II (Ang II) formed locally on nerve-stimulated purinergic and adrenergic components of double…
Expand
2002
2002
Binding of KRH‐594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors
Y. Inada
,
T. Nakane
,
Shigetoshi Chiba
Fundamental & Clinical Pharmacology
2002
Corpus ID: 22804551
We studied the binding properties of KRH‐594, a new selective antagonist of angiotensin II (AII) type 1 (AT1) receptors, to rat…
Expand
2001
2001
KRH‐594, A New Angiotensin At1 Receptor Antagonist, Prevents End‐Organ Damage In Stroke‐Prone Spontaneously Hypertensive/Izm Rats
Y. Inada
,
S. Tazawa
,
M. Murakami
,
M. Akahane
Clinical and Experimental Pharmacology and…
2001
Corpus ID: 37038020
1. In the present study, we examined whether KRH‐594, a new angiotensin AT1 receptor antagonist, would stop the progression of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE